These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16246616)

  • 1. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
    Fan GK; Chen J; Ping F; Geng Y
    Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
    Fan GK; Xu F; Yang B; Fujieda S
    Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p27 and apoptosis in oral leukoplakia.
    Tsuzuki H; Fujieda S; Sunaga H; Narita N; Tokuriki M; Saito H
    Anticancer Res; 2003; 23(2B):1265-70. PubMed ID: 12820381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
    Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
    Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
    Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
    Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
    J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [P53 expression and clinical significance in oral squamous cell carcinoma].
    Long Y; Ling D; Yue W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
    Yue H; Yu J; Zhao X; Song F; Feng X
    Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
    Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
    Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression of urokinase-type plasminogen activator in oral squamous cell carcinoma].
    Liang X; Mao Z; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):147-9. PubMed ID: 12838705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
    Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
    Greer RO; Meyers A; Said SM; Shroyer KR
    Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
    Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
    Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.